49. Radionuclide therapy of neuroendocrine and neuroectodermal tumors.: Revision history

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

4 January 2024

  • curprev 21:1021:10, 4 January 2024‎ Nikolas Sọ̀rọ̀ contribs‎ 644 bytes +644‎ Created page with "* '''Neuroendocrine (carcinoid) tumors express somatostatin receptors -> radiopharmaceuticals will bind to these receptors''' ** '''Indications''' *** Lung neuroendocrine tumors *** Adenocarcinomas of GI tract and pancreas ** '''Radiopharmaceuticals which bind to SST receptors''' *** '''111In-octreotide – indium-111-octreotide''' *** 99mTc-depreotide * '''I123-MIBG scintigraphy''' ** '''I123-MIBG binds to adrenergic receptors in neuroendocrine tumors''' ** Indications..." Tag: Visual edit